Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4926
Viant Technology
DSP
$268M
| $1.45M | ﹤0.01% |
114,205
-5,644
| -5% | -$63.6K |
2021 Q1
21 quarters
|
|
4927
TechTarget
TTGT
$273M
| $1.44M | ﹤0.01% |
401,384
+130,166
| +48% | +$597K |
2013 Q4
50 quarters
|
|
4928
iShares MSCI Global Sustainable Development Goals ETF
SDG
$159M
| $1.44M | ﹤0.01% |
16,151
+2,167
| +15% | +$194K |
2020 Q3
23 quarters
|
|
4929
Invesco Trust for Investment Grade New York Municipals
VTN
$142M
| $1.44M | ﹤0.01% |
124,698
+21,645
| +21% | +$241K |
2013 Q2
52 quarters
|
|
4930
Vanguard Ultra-Short Bond ETF
VUSB
$9.9B
| $1.44M | ﹤0.01% |
28,990
+2,790
| +11% | +$139K |
2022 Q1
17 quarters
|
|
4931
Playtika
PLTK
$805M
| $1.44M | ﹤0.01% |
386,982
+14,957
| +4% | +$51.7K |
2021 Q1
21 quarters
|
|
4932
Dakota Gold
DC
$739M
| $1.44M | ﹤0.01% |
337,638
+47,043
| +16% | +$254K |
2022 Q2
16 quarters
|
|
4933
Madison Covered Call & Equity Strategy Fund
MCN
$111M
| $1.44M | ﹤0.01% |
260,509
+9,740
| +4% | +$56.7K |
2013 Q2
52 quarters
|
|
4934
Fidelity International Multifactor ETF
FDEV
$282M
| $1.44M | ﹤0.01% |
40,435
+40,392
| +93,935% | +$1.46M |
2025 Q1
5 quarters
|
|
4935
Ginkgo Bioworks
DNA
$692M
| $1.43M | ﹤0.01% |
144,314
-315,686
| -69% | -$2.64M |
2021 Q3
19 quarters
|
|
4936
Weyco Group
WEYS
$495M
| $1.43M | ﹤0.01% |
36,353
+7,254
| +25% | +$253K |
2013 Q4
50 quarters
|
|
4937
Citizens & Northern Corp
CZNC
$457M
| $1.42M | ﹤0.01% |
61,022
+32,839
| +117% | +$725K |
2013 Q2
52 quarters
|
|
4938
Imperial Petroleum
IMPP
$221M
| $1.42M | ﹤0.01% |
308,105
+165,335
| +116% | +$804K |
2023 Q4
10 quarters
|
|
4939
Rimini Street
RMNI
$374M
| $1.42M | ﹤0.01% |
332,259
-884
| -0.3% | -$3.35K |
2017 Q4
34 quarters
|
|
4940
Eaton Vance California Municipal Income Trust
CEV
$72.4M
| $1.41M | ﹤0.01% |
134,122
+16,036
| +14% | +$165K |
2013 Q2
52 quarters
|
|
4941
Entrada Therapeutics
TRDA
$170M
| $1.41M | ﹤0.01% |
191,650
+15,524
| +9% | +$149K |
2021 Q4
18 quarters
|
|
4942
Ennis
EBF
$566M
| $1.41M | ﹤0.01% |
66,175
-10,772
| -14% | -$224K |
2013 Q2
52 quarters
|
|
4943
BNY Mellon US Small Cap Core Equity ETF
BKSE
$83M
| $1.4M | ﹤0.01% |
31,350
+16,920
| +117% | +$706K |
2022 Q3
15 quarters
|
|
4944
GH Research
GHRS
$1.25B
| $1.4M | ﹤0.01% |
52,218
+26,388
| +102% | +$551K |
2021 Q2
20 quarters
|
|
4945
Village Farms International
VFF
$309M
| $1.4M | ﹤0.01% |
698,573
-337,515
| -33% | -$844K |
2019 Q1
29 quarters
|
|
4946
Omega Flex
OFLX
$259M
| $1.4M | ﹤0.01% |
44,472
-4,682
| -10% | -$145K |
2013 Q2
52 quarters
|
|
4947
WisdomTree Trust WisdomTree Emerging Markets Quality Dividend Growth Fund
DGRE
$140M
| $1.39M | ﹤0.01% |
34,099
+2,874
| +9% | +$111K |
2013 Q3
51 quarters
|
|
4948
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
$6.08B
| $1.39M | ﹤0.01% |
24,930
+13,501
| +118% | +$732K |
2024 Q3
7 quarters
|
|
4949
Nathan's Famous
NATH
$418M
| $1.38M | ﹤0.01% |
13,630
+661
| +5% | +$66.9K |
2013 Q2
52 quarters
|
|
4950
TPG Mortgage Investment Trust
MITT
$170M
| $1.38M | ﹤0.01% |
174,253
+6,241
| +4% | +$48.7K |
2013 Q2
52 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.